Zanubrutinib (BGB-3111) in Combination With Tislelizumab (BGB-A317) in Participants With B-cell Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Lymphoma
Related studies linked through entity extraction aliases.
Durvalumab in Pediatric and Adolescent Patients
- Status
- COMPLETED
- Phase
- PHASE1
Trial of Duvelisib in Combination With Either Romidepsin or Bortezomib in Relapsed/Refractory T-cell Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
Study of ACTR087 in Subjects With Relapsed or Refractory B-cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Evaluation of a New EUS Guided Biopsy Needle (SharkCore) Comparing to Standard EUS Needle (ProCore)
- Status
- WITHDRAWN
- Phase
- PHASE2
PERCIST Criteria for Response Evaluation With Solid Tumors
- Status
- UNKNOWN
- Phase
- N/A
A Study of Itacitinib (INCB039110) in Combination With Ibrutinib in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Clinical Trial of Buparlisib and Ibrutinib in Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Early Life Exposures in Agriculture
- Status
- COMPLETED
- Phase
- N/A
MRI Compared to PET/CT for Staging and Treatment Response in Lymphoma
- Status
- UNKNOWN
- Phase
- NA
A Study to Determine Dose, Safety, and Efficacy of Durvalumab as Monotherapy and in Combination Therapy in Subjects With Lymphoma or Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS
- Status
- COMPLETED
- Phase
- PHASE3
A Study Evaluating Safety and Efficacy of Obinutuzumab, Polatuzumab Vedotin (Pola), and Atezolizumab (Atezo) in Participants With Relapsed or Refractory Follicular Lymphoma (FL) and Rituximab, Atezo, and Pola in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study Evaluating the Efficacy and Safety With CAR-T for Recurrent or Refractory Diffuse Large B Cell Lymphoma
- Status
- UNKNOWN
- Phase
- NA
Phase II Study of TAK228 in Relapsed Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplant (HSCT) For Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Use of EBUS TBNA for Cell Culture as an Aid to Diagnose Lung Cancer and Lymphoma
- Status
- COMPLETED
- Phase
- NA
A Clinical Research of CD20-Targeted CAR-T in B Cell Malignancies
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Role of Geriatric Intervention in Treatment of Older Patients With Cancer (PREPARE)
- Status
- COMPLETED
- Phase
- NA
Belinostat Combined With Azacitidine/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Refractory or Relapsed Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2